Literature DB >> 24728167

Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.

Selma B Souto1, Pedro V Baptista2, Daniel C Braga1, Davide Carvalho1.   

Abstract

Leydig cell tumors are rare ovarian steroid cell neoplasms. More than 75% of patients show signs of virilization due to overproduction of testosterone. We report a case of an 81-year-old woman with progressive signs of virilization, and presenting vaginal bleeding. Clinical analyses revealed high levels of serum testosterone, delta 4-androstenedione and estradiol, and also inappropriate low levels of gonadotrophins for a post-menopausal woman. Transvaginal ultrasound showed no evidence of ovarian tumor, but pelvic and abdominal computerized axial tomography imaging revealed a left ovarian solid nodule, and no evidence of alteration in the adrenal glands. Total hysterectomy and bilateral salpingoophorectomy were performed. Histopathology and immunohistochemistry confirmed the diagnosis of Leydig cell tumor. After surgery, androgen levels returned to normal, and there was regression of the signs of virilization.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728167     DOI: 10.1590/0004-2730000002461

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  10 in total

1.  Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.

Authors:  Ana Palha; Luísa Cortez; Ana Paula Tavares; Ana Agapito
Journal:  BMJ Case Rep       Date:  2016-11-01

Review 2.  Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists.

Authors:  Mariana Horta; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

3.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

4.  An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report.

Authors:  Shuann Shwana; Natasha Shrikrishnapalasuriyar; Win Yin; Monica Vij; Atul Kalhan
Journal:  touchREV Endocrinol       Date:  2021-04-28

5.  Hyperandrogenism in menopause: a case report and literature review.

Authors:  Andrey V Dolinko; Elizabeth S Ginsburg
Journal:  Fertil Res Pract       Date:  2015-05-19

6.  An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.

Authors:  Min Chen; Weibin Zhou; Zhe Zhang; Yuting Zou; Chengjiang Li
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

Review 7.  Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Strategies for In Vivo Administration: Part-II.

Authors:  Raquel Vieira; Selma B Souto; Elena Sánchez-López; Ana López Machado; Patricia Severino; Sajan Jose; Antonello Santini; Amelia M Silva; Ana Fortuna; Maria Luisa García; Eliana B Souto
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

8.  Diagnosis of a small Leydig cell tumor by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Authors:  Kazuya Okamura; Takeshi Yoshizako; Rika Yoshida; Asuka Araki; Satoru Kyo; Hajime Kitagaki
Journal:  Radiol Case Rep       Date:  2020-05-01

9.  Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.

Authors:  Mohamed K M Shakir; Andrea N Snitchler; Nicole O Vietor; Vinh Q Mai; Thanh D Hoang
Journal:  AACE Clin Case Rep       Date:  2020-12-28

10.  The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.

Authors:  Larisa V Suturina; Eldar M Sharifulin; Maharam A Sharifulin; Ludmila M Lazareva; Irina N Danusevich; Kseniia D Ievleva; Iana G Nadeliaeva
Journal:  Metabolites       Date:  2022-07-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.